Literature DB >> 6201038

Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.

T Lagergård, P Branefors.   

Abstract

Cross-reactivity between capsular antigens of Haemophilus influenzae types a and b, and Streptococcus pneumoniae types 6A and 6B was studied by means of comparative double diffusion, quantitative precipitin tests and enzyme-linked immunosorbent assay (ELISA). Antisera against whole bacteria were employed. When capsular antigens of S. pneumoniae types 6A and 6B were compared by means of the double diffusion technique, three antigenic determinants were distinguished, two of them being common to the two serotypes. When pneumococcal capsular antigens were compared with H. influenzae capsular antigens, cross-reactive antibodies were detectable only in anti-pneumococcal sera. The heterologous pneumococcal polysaccharide preparation precipitated about 80% of the capsular antibodies in pneumococcal antisera, while heterologous H. influenzae polysaccharide precipitated only about 20-30% of the capsular antibodies in anti-H. influenzae sera. S. pneumoniae polysaccharide precipitated 10-20% of the antibodies in antisera against. H. influenzae, and H. influenzae polysaccharide precipitated about 20-25% of the antibodies in antisera against S. pneumoniae type 6A. Approximately the same degree of cross-reactivity was revealed when ELISA was employed. The absorption study of the antisera with D-ribitol-5-phosphate indicates that this structure is responsible for the cross-reactivity between S. pneumoniae and H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6201038

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand C        ISSN: 0108-0202


  12 in total

Review 1.  Anti-pneumococcal antibody titre measurement: what useful information does it yield?

Authors:  Paul Balmer; Andrew J Cant; Ray Borrow
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Identification of Haemophilus influenzae type b by a monoclonal antibody coagglutination assay.

Authors:  J Hamel; B R Brodeur; A Belmaaza; S Montplaisir; J M Musser; R K Selander
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

4.  Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies.

Authors:  S Blumental; J C Moïsi; L Roalfe; M Zancolli; M Johnson; P Burbidge; R Borrow; S Yaro; J E Mueller; B D Gessner; D Goldblatt
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

5.  Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.

Authors:  Paul Balmer; Ray Borrow; Jamie Findlow; Rosalind Warrington; Sarah Frankland; Pauline Waight; Robert George; Nick Andrews; Elizabeth Miller
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

6.  Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Authors:  Eli B Nix; Kylie Williams; Andrew D Cox; Frank St Michael; Sandra Romero-Steiner; Daniel S Schmidt; William G McCready; Marina Ulanova
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

7.  Dynamics of naturally acquired antibody against Haemophilus influenzae type a capsular polysaccharide in a Canadian Aboriginal population.

Authors:  Angjelina Konini; Eli Nix; Marina Ulanova; Seyed M Moghadas
Journal:  Prev Med Rep       Date:  2016-01-26

8.  Characterization of natural bactericidal antibody against Haemophilus influenzae type a in Canadian First Nations: A Canadian Immunization Research Network (CIRN) Clinical Trials Network (CTN) study.

Authors:  Eli B Nix; Joshua Choi; Christina Anthes; Gabrielle N Gaultier; Joelle Thorgrimson; Andrew D Cox; Raymond S W Tsang; William G McCready; Douglas Boreham; Marina Ulanova
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

9.  Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes "a" and "b".

Authors:  Angjelina Konini; Mingsong Kang; Seyed M Moghadas
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-03-02       Impact factor: 2.471

10.  Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.

Authors:  Nadia A Charania; Seyed M Moghadas
Journal:  BMC Public Health       Date:  2017-09-13       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.